The primary objective of the proposed phase II work is to expand the product offering and successfully commercialize the MVP that was successfully developed in phase I of this sbir contract. Phase…
Ended Definitive Contract Awarded Last action
- Contract number
- 75N95020C00025
- Awardee
-
S-3 Research LLC UEI LELZHK767GF3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,499,999
Award facts
- Opportunity
-
- PHS20191 Solicitation number
- Contract value 100% obligated
- $1,499,999.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- R499 Support- Professional: Other
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 18 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92130, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,499,999 |
About this award
S-3 Research LLC has been awarded a $1.5 million firm fixed price contract by the National Institutes of Health's National Institute on Drug Abuse to further develop and commercialize a minimum viable product originally created under Phase I of the Small Business Innovation Research program. Over the next two years, the company will focus on four technical objectives to expand its product offering and successfully bring the Phase I technology to market. The award is designated for total small business participation. As the lead agency for substance abuse and addiction research, the National Institute on Drug Abuse seeks to support innovative solutions through programs like SBIR that can help address public health challenges.
Description
The primary objective of the proposed phase II work is to expand the product offering and successfully commercialize the MVP that was successfully developed in phase I of this sbir contract. Phase II will focus on four specific overarching technical
Quick answers
Who was awarded contract 75N95020C00025?
75N95020C00025 was awarded to S-3 Research LLC by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2020.
How much is contract 75N95020C00025 worth?
The government has obligated $1,499,999 on 75N95020C00025.
Was contract 75N95020C00025 competed?
The extent of competition for 75N95020C00025 was full and open competition after exclusion of sources. The government received 18 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award